Condition: Heart Disease

Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With CVD (HORIZON)

This phase 3 study is evaluating the efficacy and safety of study TQJ230 compared to placebo in the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a).

Location(s): Jacksonville (Headquarters), St. Augustine

Condition: Heart Disease

Safety and Tolerability of Abelacimab compared to Rivaroxaban in Patients With Atrial Fibrillation (AZALEA-TIMI 71)

The purpose of this phase 2 study is to evaluate the bleeding profile of abelacimab compared to rivaroxaban in patients with atrial fibrillation (AF) at moderate-to-high risk of stroke.

Location(s): Jacksonville (Headquarters), St. Augustine

Condition: Atrial Fibrillation, Heart Disease

A Study of Tirzepatide Compared to Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

This study is being done to assess the efficacy and safety of tirzepatide compared to dulaglutide in patients with type 2 diabetes and increased cardiovascular risk.

Location(s): Jacksonville- LaVilla (Downtown), Macon

Condition: Diabetes, Heart Disease

Inclisiran in Patients With Cardiovascular Disease (ORION-4)

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Lake CIty, Macon, St. Augustine

Condition: Cholesterol, Heart Disease